{"id":"W2553678345","doi":"10.1016/j.ijrobp.2016.11.026","title":"Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":732,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; University of Toronto; BC Cancer Agency","funders":"","keywords":"Medicine; Clinical endpoint; Prostate cancer; Brachytherapy; Hazard ratio; Randomized controlled trial; Androgen deprivation therapy; Urology; Radiation therapy; Survival analysis; Androgen suppression; Progression-free survival; Internal medicine; Nuclear medicine; Oncology; Surgery; Cancer; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01776587911076461,"score_gpt":0.333402815900654,"score_spread":0.3156369367898894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}